This article evaluates a novel single-photon emission computed tomography/computed tomography (VQ SPECT/CT)-derived Ventilation Perfusion Capacity Differential Index (VQCDI) for predicting post-treatment lung function in early-stage lung cancer.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
February 26, 2026
February 23, 2026
This video demonstrates a robotic S8 segmentectomy for a deep pulmonary metastasis uniquely guided by high-resolution 3D reconstruction imaging.
February 12, 2026
This study investigated whether antifibrotic therapy is associated with a reduced incidence of lung cancer in patients with idiopathic pulmonary fibrosis (IPF).
February 10, 2026
This video demonstrates a patient with an extremely rare and aggressive pulmonary artery sarcoma who underwent the Texas Two-Step procedure.
February 5, 2026
In this nationwide retrospective cohort study, the authors evaluated outcomes of minimally invasive lobectomy (MIL) vs stereotactic ablative radiotherapy (SABR) in 2,183 patients with stage I non-small cell lung cancer (NSCLC) treated between 2014 and 2016. After propensity score weighting, overall survival differed by clinical subgroups.
February 2, 2026
This video demonstrates a patient with recurrent pneumonia due to an obstructing left lower lobe bronchial neuroendocrine tumor without metastasis, who underwent a parenchyma-sparing robotic left lower lobe bronchial sleeve resection.
January 19, 2026
This video presents an extended thymectomy with en bloc left upper lobectomy using a combined video-assisted thoracoscopic surgery and sternotomy approach.
January 15, 2026
In this fascinating interview, CTSNet Editor-in-Chief Joel Dunning spoke with Drs. Michael Lanuti and thoracic surgeon and Leanne Ashrafian about Dr. Lanuti’s thoughts on the JCOG0802 trial and how he believes the wrong parameters were measured.
January 8, 2026
In this remarkable interview, CTSNet Editor-in-Chief Joel Dunning and CTSNet Senior Editor Leanne Ashrafian spoke with Dr. Gavin Wright about his thoughts on the JCOG0802 trial and why he prefers segmentectomy over lobectomy.
December 23, 2025
In this study, the authors report the long-term outcomes of the randomized phase II NEOpredict-Lung trial, which evaluates short-course neoadjuvant nivolumab with or without the LAG-3 inhibitor relatlimab in resectable non-small cell lung cancer (NSCLC).